BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshimatsu Y, Mikami Y, Kanai T. Bacteriotherapy for inflammatory bowel disease. Inflamm Regen 2021;41:3. [PMID: 33441186 DOI: 10.1186/s41232-020-00153-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Cornelia Lazăr D, Moacă E, Cornianu M, Tăban S, Faur A, Goldiș A. Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives. Benign Anorectal Disorders - An Update [Working Title] 2022. [DOI: 10.5772/intechopen.108664] [Reference Citation Analysis]
2 Ikeda Y, Taniguchi K, Yoshikawa S, Sawamura H, Tsuji A, Matsuda S. A budding concept with certain microbiota, anti-proliferative family proteins, and engram theory for the innovative treatment of colon cancer. Exploration of Medicine 2022;2:468-478. [DOI: 10.37349/emed.2022.00108] [Reference Citation Analysis]
3 Li P, Zhang HY, Gao JZ, Du WQ, Tang D, Wang W, Wang LH. Mesenchymal stem cells-derived extracellular vesicles containing miR-378a-3p inhibit the occurrence of inflammatory bowel disease by targeting GATA2. J Cell Mol Med 2022. [PMID: 35582765 DOI: 10.1111/jcmm.17176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Castillo-González R, Fernández-Delgado I, Comberiati P. Bacteriotherapy with human skin commensals in atopic dermatitis. Allergy 2022;77:1331-3. [PMID: 34713451 DOI: 10.1111/all.15162] [Reference Citation Analysis]
5 Huo X, Li D, Wu F, Li S, Qiao Y, Wang C, Wang Y, Zhou C, Sun L, Luan Z, Yan Q, Wang J, Zhang Y, Zhao T, An Y, Zhang B, Tian X, Yu Z, Ma X. Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists. Gut 2022:gutjnl-2021-325413. [PMID: 35173042 DOI: 10.1136/gutjnl-2021-325413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Komoto M, Asada A, Ohshima Y, Miyanaga K, Morimoto H, Yasukawa T, Morito K, Takayama K, Uozumi Y, Nagasawa K. Dextran sulfate sodium-induced colitis in C57BL/6J mice increases their susceptibility to chronic unpredictable mild stress that induces depressive-like behavior. Life Sci 2021;289:120217. [PMID: 34896162 DOI: 10.1016/j.lfs.2021.120217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Shen H, Zhao Z, Zhao Z, Chen Y, Zhang L. Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases. Int J Mol Sci 2022;23:594. [PMID: 35054790 DOI: 10.3390/ijms23020594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
8 Kushkevych I, Jampílek J. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00016-7] [Reference Citation Analysis]
9 Martyniak A, Medyńska-Przęczek A, Wędrychowicz A, Skoczeń S, Tomasik PJ. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules 2021;11:1903. [PMID: 34944546 DOI: 10.3390/biom11121903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]